• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Sandeep Singhal

Actis, Nexus and ChrysCapital's Dhawan win at AVCJ India awards - Update

Ashish Dhawan, the founder and senior managing director of ChrysCapital Investment Advisors who is transitioning out of his role to devote more time to philanthropy, won the AVCJ Special Achievement Award at the AVCJ Indian Private Equity and Venture...

  • South Asia
  • 02 December 2011
The changing face of Indian private equity

What's happening in Indian private equity? The past few months have seen tremendous changes in India’s PE industry as local professionals move around in a happy merry-go-round of new and old faces. Some industry watchers say these changes and movements...

  • South Asia
  • 09 March 2011
Sequoia departures put question mark over fund’s future

Four of Sequoia Capital India’s founding partners have resigned from the VC firm to set up a new fund, which will focus on domestic PIPE transactions.

  • Venture
  • 15 February 2011
Sequoia India invested $16 million in biopharmaceutical play Celon Labs

Sequoia Capital India has invested INR70 crore ($16 million) in Celon Labs, a Hyderabad-based biopharmaceutical company with established brands in oncology, critical care and gynaecology.

  • Early-stage
  • 08 October 2010
Sequoia makes partial PathLabs exit

Sequoia Capital India is making a partial exit from its investment in Dr Lal PathLabs, a leading local diagnostics and pathology chain, selling around half of its 30% stake in the business, with a probable deal value of some $25.4 million.

  • South Asia
  • 27 May 2010
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013